Cargando…

Alternative management of diabetic ketoacidosis in a Brazilian pediatric emergency department

DKA is a severe metabolic derangement characterized by dehydration, loss of electrolytes, hyperglycemia, hyperketonemia, acidosis and progressive loss of consciousness that results from severe insulin deficiency combined with the effects of increased levels of counterregulatory hormones (catecholami...

Descripción completa

Detalles Bibliográficos
Autores principales: Savoldelli, Roberta D, Farhat, Sylvia CL, Manna, Thais D
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2903515/
https://www.ncbi.nlm.nih.gov/pubmed/20550713
http://dx.doi.org/10.1186/1758-5996-2-41
_version_ 1782183808677707776
author Savoldelli, Roberta D
Farhat, Sylvia CL
Manna, Thais D
author_facet Savoldelli, Roberta D
Farhat, Sylvia CL
Manna, Thais D
author_sort Savoldelli, Roberta D
collection PubMed
description DKA is a severe metabolic derangement characterized by dehydration, loss of electrolytes, hyperglycemia, hyperketonemia, acidosis and progressive loss of consciousness that results from severe insulin deficiency combined with the effects of increased levels of counterregulatory hormones (catecholamines, glucagon, cortisol, growth hormone). The biochemical criteria for diagnosis are: blood glucose > 200 mg/dl, venous pH <7.3 or bicarbonate <15 mEq/L, ketonemia >3 mmol/L and presence of ketonuria. A patient with DKA must be managed in an emergency ward by an experienced staff or in an intensive care unit (ICU), in order to provide an intensive monitoring of the vital and neurological signs, and of the patient's clinical and biochemical response to treatment. DKA treatment guidelines include: restoration of circulating volume and electrolyte replacement; correction of insulin deficiency aiming at the resolution of metabolic acidosis and ketosis; reduction of risk of cerebral edema; avoidance of other complications of therapy (hypoglycemia, hypokalemia, hyperkalemia, hyperchloremic acidosis); identification and treatment of precipitating events. In Brazil, there are few pediatric ICU beds in public hospitals, so an alternative protocol was designed to abbreviate the time on intravenous infusion lines in order to facilitate DKA management in general emergency wards. The main differences between this protocol and the international guidelines are: intravenous fluid will be stopped when oral fluids are well tolerated and total deficit will be replaced orally; if potassium analysis still indicate need for replacement, it will be given orally; subcutaneous rapid-acting insulin analog is administered at 0.15 U/kg dose every 2-3 hours until resolution of metabolic acidosis; approximately 12 hours after treatment initiation, intermediate-acting (NPH) insulin is initiated at the dose of 0.6-1 U/kg/day, and it will be lowered to 0.4-0.7 U/kg/day at discharge from hospital.
format Text
id pubmed-2903515
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29035152010-07-14 Alternative management of diabetic ketoacidosis in a Brazilian pediatric emergency department Savoldelli, Roberta D Farhat, Sylvia CL Manna, Thais D Diabetol Metab Syndr Review DKA is a severe metabolic derangement characterized by dehydration, loss of electrolytes, hyperglycemia, hyperketonemia, acidosis and progressive loss of consciousness that results from severe insulin deficiency combined with the effects of increased levels of counterregulatory hormones (catecholamines, glucagon, cortisol, growth hormone). The biochemical criteria for diagnosis are: blood glucose > 200 mg/dl, venous pH <7.3 or bicarbonate <15 mEq/L, ketonemia >3 mmol/L and presence of ketonuria. A patient with DKA must be managed in an emergency ward by an experienced staff or in an intensive care unit (ICU), in order to provide an intensive monitoring of the vital and neurological signs, and of the patient's clinical and biochemical response to treatment. DKA treatment guidelines include: restoration of circulating volume and electrolyte replacement; correction of insulin deficiency aiming at the resolution of metabolic acidosis and ketosis; reduction of risk of cerebral edema; avoidance of other complications of therapy (hypoglycemia, hypokalemia, hyperkalemia, hyperchloremic acidosis); identification and treatment of precipitating events. In Brazil, there are few pediatric ICU beds in public hospitals, so an alternative protocol was designed to abbreviate the time on intravenous infusion lines in order to facilitate DKA management in general emergency wards. The main differences between this protocol and the international guidelines are: intravenous fluid will be stopped when oral fluids are well tolerated and total deficit will be replaced orally; if potassium analysis still indicate need for replacement, it will be given orally; subcutaneous rapid-acting insulin analog is administered at 0.15 U/kg dose every 2-3 hours until resolution of metabolic acidosis; approximately 12 hours after treatment initiation, intermediate-acting (NPH) insulin is initiated at the dose of 0.6-1 U/kg/day, and it will be lowered to 0.4-0.7 U/kg/day at discharge from hospital. BioMed Central 2010-06-16 /pmc/articles/PMC2903515/ /pubmed/20550713 http://dx.doi.org/10.1186/1758-5996-2-41 Text en Copyright ©2010 Savoldelli et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Savoldelli, Roberta D
Farhat, Sylvia CL
Manna, Thais D
Alternative management of diabetic ketoacidosis in a Brazilian pediatric emergency department
title Alternative management of diabetic ketoacidosis in a Brazilian pediatric emergency department
title_full Alternative management of diabetic ketoacidosis in a Brazilian pediatric emergency department
title_fullStr Alternative management of diabetic ketoacidosis in a Brazilian pediatric emergency department
title_full_unstemmed Alternative management of diabetic ketoacidosis in a Brazilian pediatric emergency department
title_short Alternative management of diabetic ketoacidosis in a Brazilian pediatric emergency department
title_sort alternative management of diabetic ketoacidosis in a brazilian pediatric emergency department
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2903515/
https://www.ncbi.nlm.nih.gov/pubmed/20550713
http://dx.doi.org/10.1186/1758-5996-2-41
work_keys_str_mv AT savoldellirobertad alternativemanagementofdiabeticketoacidosisinabrazilianpediatricemergencydepartment
AT farhatsylviacl alternativemanagementofdiabeticketoacidosisinabrazilianpediatricemergencydepartment
AT mannathaisd alternativemanagementofdiabeticketoacidosisinabrazilianpediatricemergencydepartment